#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic scleroderma Haemophilia A with anti factor VIII Medulloblastoma recurrent Rectal cancer Nodal marginal zone B-cell lymphoma Congenital absence of bile ducts Subdural haematoma Ovarian epithelial cancer T-cell lymphoma Usher's syndrome Metastatic malignant melanoma Penile cancer Acute promyelocytic leukaemia Pleural mesothelioma malignant Pyruvate kinase deficiency anaemia More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Trials in Disease Hereditary optic atrophy Haemophagocytic lymphohistiocytosis – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Lysosomal storage disorder – Basic Information X-linked lymphoproliferative syndrome – Treatment Retinoblastoma – Basic Information Haemophilia B with anti factor IX – Diagnostics Haemophilia Bronchiolitis obliterans syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lenacapavir Brepocitinib Tosilate Indocyanine Green Msv-Allo Bepirovirsen S230815-2 Sitravatinib Malate Valproic Acid Gadobutrol Resatorvid Itraconazole Nnc0194-0499 Brinzolamide Plitidepsin Gen1055 Mk-1942 Esketamine Hydrochloride Tozinameran Urokinase Ferric Carboxymaltose More therapies…

    Learn about Your Condition

    Cervix carcinoma Breast cancer stage IV Amnestic disorder Cardiac failure congestive Prostatitis Escherichia coli Ejection fraction normal Hodgkin's disease refractory Sexual dysfunction Dyspnoea Bile duct cancer Ovarian cancer metastatic Fatty acid oxidation disorder Herpes zoster Aphthous ulcer Left ventricular failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Embolism venous

  • Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Enoxaparin Sodium
    • SRSD107
    Bulgaria Czechia Hungary Latvia Lithuania Poland

  • Evaluation of a Single Measurement Strategy for Direct Oral Anticoagulants in Frail Older Patients with Atrial Fibrillation or Venous Thromboembolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Embolism venous
    Investigated Drugs:
    • Apixaban
    • Lactose Monohydrate
    • Rivaroxaban
    The Netherlands

  • Study on Venous Thromboembolism Prevention with Enoxaparin Sodium and Drug Combination for Patients Undergoing Total Hip or Knee Replacement

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Coagulation Factor Ii
    • Human Coagulation Factor Ix
    • Human Coagulation Factor Vii
    The Netherlands

  • Study on Apixaban for Preventing Blood Clots in Patients Undergoing Abdominal, Gynecologic, and Urologic Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Apixaban
    Finland

  • Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Rbd4059
    Bulgaria France Poland Romania

  • Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Apixaban
    Finland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!